A new report looks specifically at spending on healthcare for the privately insured in the U.S in 2014. Here are the findings.
Per capita healthcare spending for the population younger than age 65 and covered by employer-sponsored insurance (ESI) has been growing at fairly steady rates over the last five years, according to a report from the Health Care Cost Institute (HCCI), a non-profit, non-partisan research organization.
In 2014, spending grew 3.4% to $4,967 per capita, according to the report. Healthcare spending increased because of rising average price of services, while at the same time, the use of services declined. The only exception that HCCI found was with generic prescriptions: use of generic prescriptions rose in 2014.
Related:Three factors driving health-spending growth
Frost
“The privately insured population in the U.S. is quite large, and represents a sizable portion of money spent on healthcare,” says Amanda Frost, PhD, MA, senior researcher at the HCCI. “It is important to understand what healthcare services this population is using, and how much money is being spent on them. Much of what we know about the U.S. healthcare system comes from Medicare data. But the ESI population is different than the Medicare population in many important ways. The HCCI data in general, and this report specifically, allows a greater understanding of the ESI population, and provides an opportunity for unique comparisons to other populations.”
Here are six takeaways from the report:
Premiums for Employer-based Health Insurance Increased by 7% in 2024, Says KFF Report
Published: October 9th 2024 | Updated: October 9th 2024The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health benefits also found that only 18% of large employers (200 employees are more) are covering the GLP-1 weight loss drugs.
Read More
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
Parity for Mental Health — Any Progress?
October 12th 2023Laws since 1996 have sought to assure that coverage of behavioral health treatments does not take a back seat to physical medicine. Amid a national crisis in mental illness and addiction, that new world of equality has not arrived. But is it on the way?
Read More